Abstract

Aceclofenac 1.5% Pluronic Lecithin Organogel

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2009 - Veterinary Compounding

Page(s): 428

Download in electronic PDF format for $75
  • Aceclofenac 1.5% Pluronic Lecithin Organogel Page 1

Abstract

A formulation for preparing Aceclofenac 1.5% Pluronic Lecithin Organogel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • topical preparations
  • aceclofenac
  • muscle pain
  • joint pain
  • analgesia
  • analgesia
  • formulation

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2009
Pg. 428
Aceclofenac 1.5% Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 446
Aceclofenac 1.5% Gel-Cream
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 200-203
Topical Medications for Orofacial Neuropathic Pain
Author(s): Bramwell Bethany L
Jan/Feb 2022
Pg. 65-71
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Nov/Dec 2010
Pg. 514
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Nov/Dec 2010
Pg. 513
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Nov/Dec 2008
Pg. 543
Indomethacin 2% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2009
Pg. 182-190
Update on Managing Neuropathic Pain
Author(s): McNulty Jack P, Muller George
May/Jun 2010
Pg. 204-206
Managing Pain with Transdermal Ketoprofen
Author(s): Williams KaCee D
May/Jun 2009
Pg. 244
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2009
Pg. 245
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 242-246
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
May/Jun 2014
Pg. 182-188
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Author(s): Warner Meredith, Tuder Dmitry
Mar/Apr 2016
Pg. 107-113
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Author(s): Rabi Joseph
Jul/Aug 2015
Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi